Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportCardiovascular Track

Abnormal regional increase of myocardial angiotensin II type 1 receptors in hypertrophic obstructive cardiomyopathy patients as determined with 11C-KR31173 and PET/CT.

Ines Valenta, Zsolt Szabo, William Mathews, Robert Dannals, Martin Pomper, Theodore Abraham and Thomas Schindler
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 439;
Ines Valenta
4Radiology Johns Hopkins University Baltimore MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zsolt Szabo
1Johns Hopkins Medicine Baltimore MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William Mathews
2Johns Hopkins University Baltimore MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Dannals
4Radiology Johns Hopkins University Baltimore MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Pomper
4Radiology Johns Hopkins University Baltimore MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Theodore Abraham
3Cardiology Johns Hopkins University Baltimore MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Schindler
2Johns Hopkins University Baltimore MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

439

Objectives: Stimulation of the myocardial angiotensin II type 1 receptor (AT1R) by an activated renin-angiotensin system (RAS) may play a central role in the remodeling process of the left ventricle in patients with hypertrophic obstructive cardiomyopathy (HCM). In this regard, we aimed to evaluate the regional distribution of myocardial angiotensin II type 1 receptor (AT1R) with the novel radiotracer 11C-KR31173 and dynamic positron emission tomography/computed tomography (PET/CT) in HCM patients in comparison to healthy volunteers as controls (CON).

Methods: Static images were obtained for KR31173 (30 to 60 min) PET/CT. From the last image, static PET data were volumetrically sampled, and myocardial polar maps were generated. For quantitative analysis, myocardial segments defined from static KR31173 images were applied to dynamic series, and time-activity curves were obtained. Subsequently, the regional or segmental retention index (%/min) of the AT1R ligand [11C]-KR31173 was determined from dynamic images acquired with 27 frames 12 x10, 6 x 60, 4 x 180, 2 x 300, 3 x 600 seconds. Regions were grouped according to left-ventricular wall thickness with >15 mm and remote regions with <15 mm in HCM patients as determined with echocardiography.

Results: Four HCM patients and four age-matched CON with a median age of 31 (IQR: 33, 37) years were investigated and they remained without any symptoms during the PET/CT image acquisition after intravenous 11C-KR31173 application. Mean arterial blood pressures and heart rate (systolic and diastolic blood pressure 127 (129, 136) and 83 (85, 87) mmHg before vs. 128 (1130, 138) and 82 (86, 89) mmHg, respectively; and heart rate 64 (66, 68) beats/min vs. 63 (65, 70) were not significantly altered during PET/CT examination in study participants. No adverse effects were noted. In CON myocardial KR31173 uptake was mildly visually detectable and homogenous in the whole left-ventricular myocardium. In HCM patients, myocardial KR31173 uptake was regionally heterogeneous with the highest uptake in the thickened vs. remote myocardial regions. Quantified KR31173 retention index of the whole left ventricle was higher in HCM patients than in CON [1.91 (1.49, 3.27) vs. 0.43 (0.24, 0.44) %/min; p&#8804;0.05]. In HCM patients, regional evaluation of the KR31173 retention index was significantly higher in the thickened than in the remote regions [(3.97 (3.03, 8.97) vs. 0.78 (0.74, 2.16) %/min; p=0.0001]. When compared to CON, KR31173 retention was significantly higher in the thickened region [0.43 (0.24, 0.44) vs. 3.97 (3.03, 8.97) %/min; p&#8804;0.005] and not significantly in the remote region [0.43 (0.24, 0.44) vs. 0.78 (0.74, 2.16) %/min; p=0.016].

Conclusion: Noninvasive in-vivo imaging of myocardial AT1 receptor with the radiotracer 11C-KR31173 and dynamic PET/CT in signifies an abnormal increase of AT1 receptor expression in hypertrophic regions in HCM patients that may reflect a mechanistic link between an activated RAS and negative left-ventricular remodeling deserving further investigations. Research Support: Departmental Fund from Johns Hopkins University (No. 175470 to T.H. Schindler)

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 58, Issue supplement 1
May 1, 2017
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Abnormal regional increase of myocardial angiotensin II type 1 receptors in hypertrophic obstructive cardiomyopathy patients as determined with 11C-KR31173 and PET/CT.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Abnormal regional increase of myocardial angiotensin II type 1 receptors in hypertrophic obstructive cardiomyopathy patients as determined with 11C-KR31173 and PET/CT.
Ines Valenta, Zsolt Szabo, William Mathews, Robert Dannals, Martin Pomper, Theodore Abraham, Thomas Schindler
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 439;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abnormal regional increase of myocardial angiotensin II type 1 receptors in hypertrophic obstructive cardiomyopathy patients as determined with 11C-KR31173 and PET/CT.
Ines Valenta, Zsolt Szabo, William Mathews, Robert Dannals, Martin Pomper, Theodore Abraham, Thomas Schindler
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 439;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Cardiovascular Track

  • To Evaluated the Cardiac Function of Patients with Acute Myocardial Infarction by the Volume and Filling Curve of 99mTc-MIBI SPECT Myocardial Perfusion Imaging
  • Standard versus low-dose rubidium-82 dynamic positron emission tomography imaging with scanner-dependent bias correction for myocardial perfusion imaging and blood flow quantification
  • Evaluation of sympathetic function with PET 11C-hydroxyephedrine (HED) and ammonia (13N-NH3) in a canine pacing model of atrial fibrillation
Show more Cardiovascular Track

Nuclear Cardiology: New Tracers and Methods

  • Aged Related Differences and Cardiovascular Molecular Calcification a 18-NaF PET/CT Quantification of Vascular Calcification in the Common Carotid Artery Study
  • Exploratory clinical trial of [18F]GP1 for imaging arterial or venous thromboembolism using positron emission tomography: interim analysis of an open-label, single center study
Show more Nuclear Cardiology: New Tracers and Methods

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire